Twin Disc, Inc. Announces Fiscal 2017 Third-Quarter Earnings Conference Call and Press Release
Apr 28, 2017 12:00 pm UTC| Business
RACINE, Wis., April 28, 2017 -- Twin Disc, Inc. (NASDAQ:TWIN), today announced that it will release its fiscal 2017 third-quarter financial results before the market opens on Friday, May 5, 2017. In conjunction with the...
Food Safety Testing Market Size to Reach USD 8.04 Billion by 2021: Zion Market Research
Apr 28, 2017 12:00 pm UTC| Business
Sarasota, FL, April 28, 2017 -- Zion Market Research has published a new report titled “Food safety testing Market (traditional and rapid) by Technology, (pathogens, toxins, GMOs, pesticides and others) by contaminant,...
Moog Reports Second Quarter Results
Apr 28, 2017 11:55 am UTC| Business
EAST AURORA, N.Y., April 28, 2017 -- Moog Inc. (NYSE:MOG.A) (NYSE:MOG.B) announced today financial results for the quarter ended April 1, 2017. Second Quarter Highlights Diluted earnings per share of $0.88, up 4%...
Gazit-Globe Files its 2016 Annual Report on Form 20-F
Apr 28, 2017 11:50 am UTC| Business
TEL AVIV, Israel, April 28, 2017 -- Gazit-Globe (NYSE:GZT)(TSX:GZT)(TASE:GZT), announced today that, in accordance with section 203.01 of the New York Stock Exchange Listed Company Manual, Gazit-Globe has filed its 2016...
NeuLion Announces Date of First Quarter 2017 Financial Results and Quarterly Webcast
Apr 28, 2017 11:30 am UTC| Business
PLAINVIEW, N.Y., April 28, 2017 -- NeuLion, Inc. (TSX:NLN), a leading technology product and service provider that specializes in the digital video broadcasting, distribution and monetization of live and on-demand...
Apr 28, 2017 11:30 am UTC| Business
In an analysis of pooled Phase 2/3 data, ZilrettaTM (FX006) demonstrated clinically meaningful pain relief and functional improvement in patients with osteoarthritisA separate Phase 2 study shows prolonged synovial...
Apr 28, 2017 11:30 am UTC| Business
Personalized cellular immunotherapy designed to prevent transplant kidney rejection and eliminate the need for chronic anti-rejection drugs Single Phase 3 study will evaluate functional immune tolerance in HLA-matched,...